Company Number: 12478986

Analysis Date: 2025-07-29 16:56 UTC

1. Risk Rating: LOW
   The company demonstrates a consistently positive net asset position with increasing net current assets over the past five years. No overdue filings or indications of insolvency are present. The micro-entity status limits the scale but does not indicate distress.

2. Key Concerns:

• Limited scale of operations with only one employee, which may constrain operational flexibility and growth potential.
• Minimal share capital (£100) suggests limited equity buffer relative to net assets, though retained earnings appear to support net assets.
• Absence of detailed profit and loss data restricts insight into profitability trends and cash flow sustainability.

3. Positive Indicators:

• Steady growth in net current assets from £26,374 in 2020 to £45,081 in 2024, indicating solid working capital management.
• No overdue accounts or confirmation statements; compliance with statutory filing deadlines is maintained.
• The company is active and not subject to any liquidation or insolvency proceedings.
• Director has been in place since incorporation with no record of disqualification or adverse conduct.

4. Due Diligence Notes:

• Review the profit and loss statements or management accounts to assess profitability and cash flow stability.
• Verify the nature of current assets, particularly cash and receivables, to confirm liquidity quality.
• Investigate the business model and revenue streams given the specialist medical practice SIC code and minimal employee headcount.
• Confirm whether any related party transactions exist given the single director and limited staffing.
• Assess any contingent liabilities or off-balance-sheet risks not visible in micro-entity accounts.